Tapewire

NYSE · USD

BMY

BRISTOL MYERS SQUIBB CO

Export transactions ↓
Tapewire entity
1662
SEC CIK
0000014272
Parsed reports
2,253

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2020 Filed Mar 12, 2020 22:19 UTC
von Autenried PaulEVP, Chief Information Officer
Tax withholdingCommon Stock, $0.10 par value 713 $57.93 $41,304.09
Disclosure

SEC source: 0000014272-20-000128 · wf-form4_158405152623782.xml · nonDerivative · entry 3

von Autenried Paul · CIK 0001524143 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,985.066

F3 · shares: Shares withheld for payment of taxes upon vesting.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 22:19 UTC
von Autenried PaulEVP, Chief Information Officer
OtherCommon Stock, $0.10 par value 32 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000128 · wf-form4_158405152623782.xml · nonDerivative · entry 2

von Autenried Paul · CIK 0001524143 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,698.066

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 22:19 UTC
von Autenried PaulEVP, Chief Information Officer
Exercise / conversionCommon Stock, $0.10 par value 2,003 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000128 · wf-form4_158405152623782.xml · nonDerivative · entry 1

von Autenried Paul · CIK 0001524143 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,730.066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2016.

Read SEC document
March 04, 2020 Filed Mar 6, 2020 22:20 UTC
Elicker John EEVP, Investor Relations
SaleCommon Stock, $0.10 par value 15,805 $61.01 $964,263.05
Disclosure

SEC source: 0000014272-20-000094 · wf-form4_158353323372031.xml · nonDerivative · entry 1

Elicker John E · CIK 0001554788 · EVP, Investor Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,665.583

F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $60.97 to $61.05, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionOption (right to buy) · Derivative 8,489 $0.00 Strike: $38.41 $0.00
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · derivative · entry 12

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,468

Underlying: Common Stock, $0.10 par value · 8,489 shares

Expires 2028-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares are currently exercisable.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionOption (right to buy) · Derivative 8,489 $0.00 Strike: $47.81 $0.00
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · derivative · entry 11

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,469

Underlying: Common Stock, $0.10 par value · 8,489 shares

Expires 2028-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares are currently exercisable.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionOption (right to buy) · Derivative 8,489 $0.00 Strike: $44.70 $0.00
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · derivative · entry 10

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,469

Underlying: Common Stock, $0.10 par value · 8,489 shares

Expires 2028-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares are currently exercisable.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionOption (right to buy) · Derivative 24,466 $0.00 Strike: $54.29 $0.00
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · derivative · entry 9

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,466

Underlying: Common Stock, $0.10 par value · 24,466 shares

Expires 2027-10-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares are currently exercisable.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionOption (right to buy) · Derivative 43,535 $0.00 Strike: $54.94 $0.00
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · derivative · entry 8

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,515

Underlying: Common Stock, $0.10 par value · 43,535 shares

Expires 2026-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the shares are currently exercisable.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
SaleCommon Stock, $0.10 par value 84,308 $60.59 $5,108,221.72
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 6

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,343

F1 · shares: 84,308 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from 60.33 to 60.71, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F1 · price: 84,308 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from 60.33 to 60.71, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 8,489 $38.41 $326,062.49
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 5

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,651

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 8,489 $47.81 $405,859.09
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 4

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 8,489 $44.70 $379,458.30
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 3

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 24,466 $54.29 $1,328,259.14
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,184

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 23:19 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 43,535 $54.94 $2,391,812.90
Disclosure

SEC source: 0000014272-20-000092 · wf-form4_158336396499135.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
AHMED NADIMPresident, Hematology
Exercise / conversionRestricted Stock Units · Derivative 17,204 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000088 · wf-form4_158328384746829.xml · derivative · entry 4

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,410

Underlying: Common Stock, $0.10 par value · 17,204 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
AHMED NADIMPresident, Hematology
Tax withholdingCommon Stock, $0.10 par value 8,473 $59.06 $500,415.38
Disclosure

SEC source: 0000014272-20-000088 · wf-form4_158328384746829.xml · nonDerivative · entry 2

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,555

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units awards.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
AHMED NADIMPresident, Hematology
Exercise / conversionCommon Stock, $0.10 par value 17,204 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000088 · wf-form4_158328384746829.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 24,579 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000089 · wf-form4_158328387038941.xml · derivative · entry 4

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,156

Underlying: Common Stock, $0.10 par value · 24,579 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
Elkins David VEVP, Chief Financial Officer
Tax withholdingCommon Stock, $0.10 par value 10,470 $59.06 $618,358.20
Disclosure

SEC source: 0000014272-20-000089 · wf-form4_158328387038941.xml · nonDerivative · entry 2

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,296

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:04 UTC
Elkins David VEVP, Chief Financial Officer
Exercise / conversionCommon Stock, $0.10 par value 24,579 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000089 · wf-form4_158328387038941.xml · nonDerivative · entry 1

Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:05 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 23,349 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000090 · wf-form4_158328389331194.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,699

Underlying: Common Stock, $0.10 par value · 23,349 shares

Expires 2022-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:05 UTC
Vessey RupertPres., Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 8,923 $59.06 $526,992.38
Disclosure

SEC source: 0000014272-20-000090 · wf-form4_158328389331194.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,183

F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:05 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 23,349 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000090 · wf-form4_158328389331194.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on March 1, 2020.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:48 UTC
AHMED NADIMPresident, Hematology
Exercise / conversionRestricted Stock Units · Derivative 2,076 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000078 · wf-form4_158104011239112.xml · derivative · entry 4

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,152

Underlying: Common Stock, $0.10 par value · 2,076 shares

Expires 2022-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:48 UTC
AHMED NADIMPresident, Hematology
Tax withholdingCommon Stock, $0.10 par value 1,071 $64.29 $68,854.59
Disclosure

SEC source: 0000014272-20-000078 · wf-form4_158104011239112.xml · nonDerivative · entry 2

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,824

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:48 UTC
AHMED NADIMPresident, Hematology
Exercise / conversionCommon Stock, $0.10 par value 2,076 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000078 · wf-form4_158104011239112.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · President, Hematology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:49 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionRestricted Stock Units · Derivative 3,592 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000079 · wf-form4_158104013763753.xml · derivative · entry 4

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,185

Underlying: Common Stock, $0.10 par value · 3,592 shares

Expires 2022-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F1 · shares: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

F1 · derivative.expiration_date: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:49 UTC
Vessey RupertPres., Research & Early Dev.
Tax withholdingCommon Stock, $0.10 par value 1,163 $64.29 $74,769.27
Disclosure

SEC source: 0000014272-20-000079 · wf-form4_158104013763753.xml · nonDerivative · entry 2

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,757

F2 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 01:49 UTC
Vessey RupertPres., Research & Early Dev.
Exercise / conversionCommon Stock, $0.10 par value 3,592 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000079 · wf-form4_158104013763753.xml · nonDerivative · entry 1

VESSEY RUPERT · CIK 0001677618 · Pres., Research & Early Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock unit vests in three equal installments beginning on February 4, 2020.

Read SEC document
February 03, 2020 Filed Feb 26, 2020 21:43 UTC
Metcalfe KathrynEVP, Corporate Affairs
GrantRestricted Stock Units · Derivative 13,870 $0.00 $0.00
Disclosure

SEC source: 0000014272-20-000084 · wf-form4_158275340433152.xml · derivative · entry 1

Metcalfe Kathryn · CIK 0001799597 · EVP, Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,870

Underlying: Common Stock, $0.10 par value · 13,870 shares

Expires 2024-02-03

F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F2 · date: The transaction on this form was not reported in a timely manner due to an administrative error.

F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on February 3, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on February 3, 2021.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 22:59 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000058 · wf-form4_158085715087429.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,204.285

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:02 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000059 · wf-form4_158085733724072.xml · derivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,007.609

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:04 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000060 · wf-form4_158085747868474.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,801.314

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:05 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000061 · wf-form4_158085750018445.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,244.689

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:06 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000062 · wf-form4_158085757530344.xml · derivative · entry 1

GROBSTEIN MICHAEL · CIK 0001222342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,819.089

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:06 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000063 · wf-form4_158085760016384.xml · derivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,853.241

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:07 UTC
LACY ALAN JDirector
GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000064 · wf-form4_158085763432378.xml · derivative · entry 1

LACY ALAN J · CIK 0001200232 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,572.901

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:07 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000065 · wf-form4_158085765468544.xml · derivative · entry 1

Paliwal Dinesh C · CIK 0001360224 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,136.783

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:08 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000066 · wf-form4_158085770004538.xml · derivative · entry 1

Samuels Theodore R. II · CIK 0001688276 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,769.064

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:09 UTC
SATO VICKI LDirector
GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000067 · wf-form4_158085771887023.xml · derivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,459.893

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:10 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000068 · wf-form4_158085778986823.xml · derivative · entry 1

Storch Gerald L · CIK 0001205004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,020.947

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:10 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000069 · wf-form4_158085780915987.xml · derivative · entry 1

Vousden Karen H · CIK 0001723884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,635.627

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 01, 2020 Filed Feb 4, 2020 23:10 UTC GrantDeferred Share Units · Derivative 3,018.268 $62.95 $189,999.97
Disclosure

SEC source: 0000014272-20-000070 · wf-form4_158085782987758.xml · derivative · entry 1

YALE PHYLLIS R · CIK 0001269070 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,853.241

Underlying: Common Stock, $0.10 par value · 3,018.268 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:48 UTC GrantDeferred Share Units · Derivative 564.73 $64.19 $36,250.02
Disclosure

SEC source: 0000014272-20-000014 · wf-form4_157809526619471.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,030.097

Underlying: Common Stock, $0.10 par value · 564.73 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:48 UTC GrantDeferred Share Units · Derivative 516.046 $64.19 $33,124.99
Disclosure

SEC source: 0000014272-20-000015 · wf-form4_157809528682368.xml · derivative · entry 1

BERTOLINI ROBERT J · CIK 0001270263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,869.941

Underlying: Common Stock, $0.10 par value · 516.046 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:48 UTC GrantDeferred Share Units · Derivative 126.239 $64.19 $8,103.28
Disclosure

SEC source: 0000014272-20-000016 · wf-form4_157809530940270.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 782.152

Underlying: Common Stock, $0.10 par value · 126.239 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:49 UTC GrantDeferred Share Units · Derivative 564.73 $64.19 $36,250.02
Disclosure

SEC source: 0000014272-20-000017 · wf-form4_157809533063118.xml · derivative · entry 1

Emmens Matthew · CIK 0001298332 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,105.355

Underlying: Common Stock, $0.10 par value · 564.73 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:49 UTC GrantDeferred Share Units · Derivative 272.628 $64.19 $17,499.99
Disclosure

SEC source: 0000014272-20-000018 · wf-form4_157809535181794.xml · derivative · entry 1

GROBSTEIN MICHAEL · CIK 0001222342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,211.873

Underlying: Common Stock, $0.10 par value · 272.628 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 23:49 UTC GrantDeferred Share Units · Derivative 177.802 $64.19 $11,413.11
Disclosure

SEC source: 0000014272-20-000019 · wf-form4_157809537433269.xml · derivative · entry 1

Haller Julia A · CIK 0001656082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833.715

Underlying: Common Stock, $0.10 par value · 177.802 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.